Proline-rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma Through Induction of Epithelial to Mesenchymal Transition

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2011 May 3

PMID 21533080

Citations 27

Authors

Chris K Sun

Kevin T Ng

Zophia X Lim

Qiao Cheng

Chung Mau Lo

Ronnie T Poon

Kwan Man

Nathalie Wong

Sheung Tat Fan

Affiliations

Soon will be listed here.

Abstract

Aims: Proline-rich tyrosine kinase 2 (Pyk2), a non-receptor tyrosine kinase of the focal adhesion kinase (FAK) family, is up-regulated in more than 60% of the tumors of hepatocellular carcinoma (HCC) patients. Forced overexpression of Pyk2 can promote the proliferation and invasion of HCC cells. In this study, we aimed to explore the underlying molecular mechanism of Pyk2-mediated cell migration of HCC cells.

Methodology/principal Findings: We demonstrated that Pyk2 transformed the epithelial HCC cell line Hep3B into a mesenchymal phenotype via the induction of epithelial to mesenchymal transition (EMT), signified by the up-regulation of membrane ruffle formation, activation of Rac/Rho GTPases, down-regulation of epithelial genes E-cadherin and cytokeratin as well as promotion of cell motility in presence of lysophosphatidic acid (LPA). Suppression of Pyk2 by overexpression of dominant negative PRNK domain in the metastatic HCC cell line MHCC97L transformed its fibroblastoid phenotype to an epithelial phenotype with up-regulation of epithelial genes, down-regulation of mesenchymal genes N-cadherin and STAT5b, and reduction of LPA-induced membrane ruffle formation and cell motility. Moreover, overexpression of Pyk2 in Hep3B cells promoted the phosphorylation and localization of mesenchymal gene Hic-5 onto cell membrane while suppression of Pyk2 in MHCC97L cells attenuated its phosphorylation and localization.

Conclusion: These data provided new evidence of the underlying mechanism of Pyk2 in controlling cell motility of HCC cells through regulation of genes associated with EMT.

Citing Articles

Opposing Functions of Maspin Are Regulated by Its Subcellular Localization in Lung Squamous Cell Carcinoma Cells.

Matsushige T, Sakabe T, Mochida H, Umekita Y Cancers (Basel). 2024; 16(17).

PMID: 39272867 PMC: 11394258. DOI: 10.3390/cancers16173009.

Proline, a unique amino acid whose polymer, polyproline II helix, and its analogues are involved in many biological processes: a review.

Umumararungu T, Gahamanyi N, Mukiza J, Habarurema G, Katandula J, Rugamba A Amino Acids. 2024; 56(1):50.

PMID: 39182198 PMC: 11345334. DOI: 10.1007/s00726-024-03410-9.

Activated PyK2 and Its Associated Molecules Transduce Cellular Signaling from the Cancerous Milieu for Cancer Metastasis.

Lee D, Hong J Int J Mol Sci. 2022; 23(24).

PMID: 36555115 PMC: 9779422. DOI: 10.3390/ijms232415475.

Physiological and pathological roles of Hic‑5 in several organs (Review).

Yao S, Tu Z, Yang X, Zhang L, Zhong Y, Zheng L Int J Mol Med. 2022; 50(5).

PMID: 36222304 PMC: 9558762. DOI: 10.3892/ijmm.2022.5194.

Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis.

Wang Y, Dong C, Zhou B Genes Dis. 2020; 7(2):172-184.

PMID: 32215287 PMC: 7083713. DOI: 10.1016/j.gendis.2019.09.012.

References

Li X, Martinez-Ferrer M, Botta V, Uwamariya C, Banerjee J, Bhowmick N . Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness. Oncogene. 2010; 30(2):167-77. PMC: 3021901. DOI: 10.1038/onc.2010.400. View

Lee T, Man K, Poon R, Lo C, Yuen A, Ng I . Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res. 2006; 66(20):9948-56. DOI: 10.1158/0008-5472.CAN-06-1092. View

Quesnelle K, Boehm A, Grandis J . STAT-mediated EGFR signaling in cancer. J Cell Biochem. 2007; 102(2):311-9. DOI: 10.1002/jcb.21475. View

Stracke M, Liotta L . Multi-step cascade of tumor cell metastasis. In Vivo. 1992; 6(4):309-16. View

Huber M, Kraut N, Beug H . Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005; 17(5):548-58. DOI: 10.1016/j.ceb.2005.08.001. View

Mathurin P, Rixe O, Carbonell N, Bernard B, Cluzel P, Bellin M . Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?. Aliment Pharmacol Ther. 1998; 12(2):111-26. DOI: 10.1046/j.1365-2036.1998.00286.x. View

Shibanuma M, Mashimo J, Kuroki T, Nose K . Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem. 1994; 269(43):26767-74. View

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

Brown M, CURTIS M, Turner C . Paxillin LD motifs may define a new family of protein recognition domains. Nat Struct Biol. 1998; 5(8):677-8. DOI: 10.1038/1370. View

10.

Nishiya N, Sabe H, Nose K, Shibanuma M . The LIM domains of hic-5 protein recognize specific DNA fragments in a zinc-dependent manner in vitro. Nucleic Acids Res. 1998; 26(18):4267-73. PMC: 147841. DOI: 10.1093/nar/26.18.4267. View

11.

Hay E . An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 1995; 154(1):8-20. DOI: 10.1159/000147748. View

12.

Teng Y, Zeisberg M, Kalluri R . Transcriptional regulation of epithelial-mesenchymal transition. J Clin Invest. 2007; 117(2):304-6. PMC: 1783811. DOI: 10.1172/JCI31200. View

13.

Tumbarello D, Turner C . Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway. J Cell Physiol. 2007; 211(3):736-47. DOI: 10.1002/jcp.20991. View

14.

Moustakas A, Heldin C . Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007; 98(10):1512-20. PMC: 11158989. DOI: 10.1111/j.1349-7006.2007.00550.x. View

15.

Farazi P, DePinho R . Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006; 6(9):674-87. DOI: 10.1038/nrc1934. View

16.

Matsuya M, Sasaki H, Aoto H, Mitaka T, Nagura K, Ohba T . Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions. J Biol Chem. 1998; 273(2):1003-14. DOI: 10.1074/jbc.273.2.1003. View

17.

Tse J, Kalluri R . Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem. 2007; 101(4):816-29. DOI: 10.1002/jcb.21215. View

18.

Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, VAN Roy F . Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991; 66(1):107-19. DOI: 10.1016/0092-8674(91)90143-m. View

19.

Frixen U, Behrens J, Sachs M, Eberle G, Voss B, Warda A . E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991; 113(1):173-85. PMC: 2288921. DOI: 10.1083/jcb.113.1.173. View

20.

Lee T, Poon R, Yuen A, Ling M, Kwok W, Wang X . Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006; 12(18):5369-76. DOI: 10.1158/1078-0432.CCR-05-2722. View